Answers are grounded in this paper and cite their sources.
Innovative Digital Twin approach predicts long-term treatment toxicities in young cancer survivors, suggesting personalized therapy potential.
Although treatment of childhood and young adult cancer has enormously progressed, long-term treatment-related toxicities (LLCTT) prevent survivors from leading a healthy life. Predictive markers are essential for identifying LLCTT early enough to enable personalised therapies that minimise risks. The complexity of LLCTT poses challenges in developing predictive markers using conventional approaches. Here, we provide an overview of how an innovative strategy, Digital Twins, harnesses recent advances in computational modelling to predict and eventually manage treatment toxicities via a personalised approach. We also address the challenges that must be overcome to integrate these models into paediatric cancer care effectively.
No takes yet. Share an insight, caveat, or question.
Elsayed et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: